Inhibition of methotrexate-induced chromosomal damage by vanillin and chlorophyllin in V79 cells

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 17, Issue 6, 1997, Pages 313-326

  Keshava, Channa ^a,b   Keshava, Nagalakshmi ^a,b   Whong, Wen Zong ^b   Nath, Joginder ^a   Ong, Tong Man ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Antigenotoxic agents; Antimutagens; Chlorophyllin; Chromosomal aberrations; Methotrexate; Micronucleus; Vanillin

Indexed keywords

CHLOROPHYLL; CYTOCHALASIN B; METHOTREXATE; VANILLIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CHINESE HAMSTER; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONTROLLED STUDY; DNA DAMAGE; GENOTOXICITY; MICRONUCLEUS TEST; MITOSIS INDEX; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0031406377     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1997)17:6<313::AID-TCM2>3.0.CO;2-K     Document Type: Article

References (36)

1. Li J, Kaminskas E: Accumulation of DNA strand breaks and methotrexate cytotoxicity. Proc Natl Acad Sci USA 81:5694-5698, 1984.
2. Mondello C, Giorgi R, Nuzzo F: Chromosomal effects of methotrexate on cultured human lymphocytes. Mutat Res 139:67-70, 1984.
3. Benedict WP, Banerjee A, Gardner A, Jones PA: Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damage in hamster A (T1)C1-3 cells by cancer chemotherapeutic agents. Cancer Res 37:2202-2208, 1977.
4. McBurney MW, Whitmore GF: Mechanism of growth inhibition by methotrexate. Cancer Res 35:586-590, 1975.
5. Polyzos A, Tsavaris N, Giannopoulos N, Archimandritis A, Papachristodoulou A, Kosmidis P: Biochemical modulation of fluorouracil: Comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer. A randomized trial. Cancer Chemother Pharmacol 38:292-297, 1996.
6. Dalen H, Oftebro R, Engeset A: The effect of methotrexate and leucovorin on cell division in Chang cells. Cancer 18:41-48, 1965.
7. Yamamoto KI, Kikuchi Y: Studies on micronuclei time response and on the effects of multiple treatment of mutagens on induction of micronuclei. Mutat Res 90:163-173, 1981.
8. Hayashi M, Sofuni T, Morita T: Simulation study of the effects of multiple treatments in the mouse bone marrow micronucleus test. Mutat Res 252:281-287, 1991.
9. Kasahara Y, Nakai Y, Miura D, Yagi K, Hirabayashi K, Makita T: Mechanisms of induction of micronuclei and chromosome aberrations in mouse bone marrow by multiple treatments of methotrexate. Mutat Res 280:117-128, 1992.
10. Kasahara Y, Wakata A, Nakai Y, Yuno K, Miura D, Yagi K, Hirabayashi K, Makita T: The micronucleus test using peripheral blood reticulocytes from methotrexate-treated mice. Mutat Res 278:145-151, 1992.
11. Kasahara Y, Nakai Y, Miura D, Kanatani H, Yagi K, Hirabayashi K, Takahashi Y, Izawa Y: Decrease in deoxyribonucleotide triphosphate pools and induction of alkaline labile sites in mouse bone marrow cells by multiple treatments with methotrexate. Mutat Res 319:143-149, 1993.
12. Ohta T: Modification of genotoxicity by naturally occurring flavorings and their derivatives. Crit Rev Toxicol 23:127-146, 1993.
13. Ferguson LR: Antimutagens as cancer chemopreventive agents in the diet. Mutat Res 307:395-410, 1994.
14. Imanishi H, Sasaki YF, Matasumoto K, Watanabe M, Ohta T, Shirasu Y, Tutikawa K: Suppression of 6-TG-resistant mutations in V79 cells and recessive spot formation in mice by vanillin. Mutat Res 243:151-158, 1990.
15. Inouye T, Sasaki YF, Imanishi H, Watanabe M, Ohta T, Shirasu Y: Suppression of mitomycin C-induced micronuclei in mouse bone marrow cells by post treatment with vanillin. Mutat Res 202:93-95, 1988.
16. Sasaki YF, Imanishi H, Ohta T, Shirasu Y: Effect of vanillin on sister-chromatid exchanges and chromosome aberrations induced by mitomycin C in cultured Chinese hamster ovary cells. Mutat Res 191:193-200, 1987.
17. 2 in cultured Chinese hamster cells. Mutat Res 268:231-237, 1992.
18. Waters MD, Stack HF, Jackson MA, Brockman HE, De Flora S: Activity profiles of antimutagens: In vitro and in vivo data. Mutat Res 350:109-129, 1996.
19. Sarkar D, Sharma A, Talukder G: Chlorophyll and chlorophyllin as modifiers of genotoxic effects. Mutat Res 318:239-247, 1994.
20. Arimoto S, Fukuoka S, Itome C, Nakano H, Rai H, Hayatsu H: Binding of polycyclic planar mutagens to chlorophyllin resulting in inhibition of the mutagenic activity. Mutat Res 287:293-305, 1993.
21. Ong T, Whong W-Z, Stewart J, Brockman HE: Chlorophyllin: A potent antimutagen against environmental and dietary complex mixtures. Mutat Res 173:111-115, 1986.
22. Wu ZL, Chen JK, Ong T, Brockman HE, Whong W-Z: Antitransforming activity of chlorophyllin against selected carcinogens and complex mixtures. Teratogen Carcinog Mutagen 14:75-81, 1994.
23. Sugiyama C, Shinoda A, Hayatsu H, Negishi T: Inhibition of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-mediated DNA-adduct formation by chlorophyllin in Drosophila. Jpn J Cancer Res 87:325-328, 1996.
24. Pienkowska K, Koziorowska J: Influence of folinic acid (leucovorin) on the cytostatic and cytogenetic effects of methotrexate. Folia Med Cracov 27:239-244, 1986.
25. Abraham SK, Sarma L, Kesavan PC: Role of chlorophyllin as an in vivo anticlastogen: Protection against gamma-radiation and chemical clastogens. Mutat Res 322:209-212, 1994.
26. Fenech M, Morley AA: Measurement of micronuclei in lymphocytes. Mutat Res 147:29-36, 1985.
27. Wakata A, Sasaki M: Measurement of micronuclei by cytokinesis-block method in cultured Chinese hamster cells: Comparison with types and rates of chromosome aberrations. Mutat Res 190:51-57, 1987.
28. Ames B, McCann J, Yamasaki E: Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347-364, 1975.
29. Krishna G, Kropko ML, Theiss JC: Use of the cytokinesis-block method for the analysis of micronuclei in V79 Chinese hamster lung cells: Results with mitomycin C and cyclophosphamide. Mutat Res 222:63-69, 1989.
30. Countryman P, Heddle JA: The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat Res 41:321-332, 1976.
31. Roberts CJ, Morgan GR, Holt PD: A critical comparison of the micronucleus yield from high and low LET irradiation of plateau phase cell population. Mutat Res 160:237-242, 1986.
32. Galloway SM, Aardema MJ, Ishidate M Jr, Ivett JL, Kirkland DJ, Mortia T, Mosesso P, Sofuni T: Report from working group on in vitro tests for chromosomal aberrations. Mutat Res 312:241-261, 1994.
33. Keshava C, Nagalakshmi R, Ong T, Nath J: Inhibitory effect of folinic acid on radiation-induced micronuclei and chromosomal aberrations in V79 cells. Mutat Res 352:123-134, 1996.
34. Nath J, Keshava C, Ong T: Protective effect of vanillin on radiation-induced micronuclei and chromosomal aberrations in V79 cells. Environ Mol Mutagen 27(Suppl 27):51, 1996.
35. Sasaki YF, Imanishi H, Watanabe M, Ohta T, Shirasu Y: Suppressing effect of antimutagenic flavorings on chromosome aberrations induced by UV-light or X-rays in cultured Chinese hamster cells. Mutat Res 229:1-10, 1990.
36. Ong T, Whong W-Z, Stewart J, Brockman HE: Comparative antimutagenicity of 5 compounds against 5 mutagenic complex mixtures in Salmonella typhimurium strain TA 98. Mutat Res 222:19-25, 1989.